Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study by Yohannes Zenebe et al.
RESEARCH ARTICLE Open Access
Sero-prevalence and risk factors of hepatitis B
virus and human immunodeficiency virus
infection among pregnant women in Bahir Dar
city, Northwest Ethiopia: a cross sectional study
Yohannes Zenebe*, Wondemagegn Mulu, Mulat Yimer and Bayeh Abera
Abstract
Background: Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) are the two most important agents
of infectious diseases. Both HBV and HIV share common modes of transmission and have serious effects on both
pregnant women and infants. In Bahir Dar city administration, there is a scarcity of information on sero-prevalence
of HIV and HBV infection among pregnant women. The main objective of this study was to assess sero-prevalence
and risk factors of HIV and HBV infection among pregnant women attending antenatal care in Bahir Dar city,
Northwest Ethiopia.
Methods: A cross-sectional study was conducted from March 2013 to April 2013. Socio-demographic and explanatory
variables were collected using a structured questionnaire by face to face interview. Hepatitis B surface antigen (HBsAg)
was detected using an enzyme linked immunosorbent assay (ELISA). HIV infection was also detected using the national
HIV test algorithms. The results were analyzed with descriptive statistics and binary logistic regression. The odds ratio
and 95% Confidence intervals were calculated.
Results: A total of 318 pregnant women with the mean age of 25.72 (SD. ±5.14) years old were enrolled. Overall,
21/318 (6.6%) and 12 /318 (3.8%) of the pregnant women were positive for HIV and HBsAg, respectively. Of these,
HIV/HBV co-infection rate was 4 (19.0%). Previous history of blood transfusion (AOR = 3.7, 95% CI, 9.02-14.84), body
tattooing (AOR = 5.7, 95% CI, 1.24-26.50), history of surgery (AOR = 11.1, 95% CI, 2.64-46.88) and unsafe injection
(AOR = 5.6, 95% CI, 1.44-22.19) were significantly associated with HBV infection. Previous history of piercing with sharp
materials (AOR = 3.0, 95% CI 1.17-7.80) and history of abortion (AOR = 6.6, 95% CI 2.50-17.71) were also statistically
significant for HIV infection.
Conclusions: This study indicates that HIV and HBV infections are important public health issues in our region that
need to be addressed. All pregnant women need to be screened for both HIV and HBV infections during antenatal
care. Furthermore, health education about modes of transmission of HIV and HBV has to be given.
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Background
Human immunodeficiency virus (HIV) and Hepatitis B
virus (HBV) infections are the two most important in-
fectious diseases throughout the world particularly in
developing countries. Both HIV and HBV share common
ways of transmission in humans, which accounts for the
high frequency of HIV-HBV co-infections. HIV and
HBV have common risk factors like injectable drug use
and blood transfusion [1]. In Ethiopia, the overall of
prevalence of HIV among pregnant women attending
anti-natal care (ANC) was 5.3%. Moreover, the preva-
lence was higher in pregnant women from urban (9.5%)
than rural areas (2.2%) [2].
Hepatitis B virus causes both acute and chronic hepa-
titis. The global prevalence of chronic HBV infection is
clustered as high (≥8%), intermediate (2-7%) and low
(<2%). Thus, Ethiopia belongs to the high prevalence
category [3]. Chronic active hepatitis B virus infection
results in cirrhosis and hepatocellular carcinoma [4,5].
The probability of becoming a chronic HBV carrier is in-
versely related to age at the time of infection. Neonatal
HBV infection always leads to a chronic carrier state
[6,7]. Chronic HBV infection at birth occurs in appro-
ximately 90% of infants born from mothers who are
positive for hepatitis B surface antigen (HBsAg) and
hepatitis B e-antigen (HBeAg) [8]. In addition, maternal
transmission of HBV predisposes infected newborns to
liver cirrhosis and hepatocellular carcinoma in young
adulthood [9]. HBV infection in infancy usually leads to
a chronic carrier and then leads to liver cirrhosis and he-
patocellular carcinoma. Therefore, the prevention of ver-
tical transmission of HBV is very important, [10].
Co-infection rate of hepatitis B virus and HIV is com-
mon which leads to increased morbidity and mortality
as compared to HIV or HBV mono-infections [11,12].
The prevalence of HIV-HBV co-infection is reported as
high as 10-20% in countries where HBV infection is
either endemic or intermediate to high [11]. Moreover,
in countries where the viruses are highly endemic, the
rate can be as high as 20-25% [11,13]. Both HIV and
HBV are transmitted via sexual intercourse and mothers
to offsprings. Thus, the prevalence of HIV and HBV
infection in pregnant women can represent the major-
ities of the population in the communities because preg-
nant women are the interface for their sexual partners
and infants.
Studies in Ethiopia have indicated that HBV and HIV
are endemic with regional variation [14-16]. However,
there is a scarcity of information on the prevalence of
HBV and HIV infection among pregnant women in the
study area. The present study was conducted to assess
the sero-prevalence of HBV and HIV infection among
pregnant women and to identify risk factors associated
with HBV and HIV infection in Bahir Dar city.
Methods
Study area, period and design
A cross-sectional study was carried out from March
2013 to April 2013. The study was conducted in Bahir
Dar administrative city. Bahir Dar is the capital of the
Amhara National Regional State. The city is situated on
the southern shore of Lake Tana, the source of the Blue
Nile. It is located approximately 578 km Northwest of
Addis Ababa, having a latitude and longitude of 11°36′N
37°23′E Coordinates and an elevation of 1840 meters
above sea level. Based on the 2007 census conducted by
the Central Statistical Agency of Ethiopia (CSA), Bahir
Dar Special Zone has a total population of 221,991. Of
these, 51.14% and 81.16% of them are females and urban
dwellers respectively (18). In the city, there is one gov-
ernmental referral hospital and ten health centers. The
study participants were enrolled from the hospital and
three randomly selected health centers.
Sample size determination and sampling technique
The study population was all pregnant women who
attended antenatal care from the selected hospital and
health centers during a data collection time. The single
population proportion formula was used to determine
the sample size by considering 7.3% prevalence of HBV
[14], 95% CI and a 3% margin of error. Accordingly, a
total of 318 study participants was included. The num-
ber of participants in each of the selected health institu-
tions was allocated proportionally based on the previous
registered annual number of clients and a systematic
random sampling technique was used to select the
study participants.
Data collection
A semi-structured questionnaire was used to collect
socio-demographic and other explanatory variables of
the study participants by face to face interview.
Laboratory investigation
Detection of HBsAg
The presence of hepatitis B surface antigens (HBsAg)
in serum was detected using EILSA (Linear chemicals.
Joaquim Costa, Barcelona, Spain) according to the
manufacturer’s instructions.
HIV screening
HIV infection among pregnant women was determined
by anti-HIV antibody test (rapid test currently used
in national algorithm for Ethiopia). KHB (Shanghai
Kehua Bio-engineering Co., Ltd. China) was used for
the first screening and positive samples were re-tested
with STAT-PACK (Chembio HIV 1/2 STATPAK™ Assay,
CHEMBIO DIAGNOSTIC SYSTEMS, INC., MEDFORD,
NY, USA). Samples giving discordant results in the two
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tests were re-examined using tie-breaker, (Uni-Gold HIV,
Trinity Biotech PLC, Wicklow, Ireland).
Quality control
To make sure that the questionnaire was appropriate
and understandable, it was pretested on 30 pregnant
women at the health center other than the actual
study sites. The collected data were checked daily for
consistency and accuracy. Standardized procedures were
strictly followed during blood sample collection, storage
and analytical process. Positive and negative controls
were run alongside of the test.
Statistical analysis
Data was entered and analyzed using SPSS version 16.0.
Binary logistic regression analysis was done to determine
the association between explanatory variables and the
outcome variables. All explanatory variables with a p-
value less than or equal to 0.2 in the bivariate analysis
were included in the multivariate logistic regression
model to identify variables which were associated inde-
pendently. Odds ratio (OR) and their 95% confidence
intervals (CI) were calculated and the result was consid-
ered statistically significant at p < 0.05.
Ethical considerations
The study was conducted after obtaining ethical clear-
ance from an ethical review committee of College of
Medicine and Health Sciences, Bahir Dar University.
Verbal consent was also secured from each study partici-
pant. HBsAg and HIV positive results were reported to
physicians and/or health officers for treatment and any
provision of antenatal care. Information on any course
of the study was kept confidential. In addition, the clin-
ical specimen collected during the study period was used
for only the stated objectives.
Results
Socio-demographic characteristics
A total of 318 pregnant women took part in this study.
Of whom, 214 (67.3%) were living in an urban setting.
The mean age of the study participants was 25.72 (SD.
±5.14) years old. The majority of the study participants
were housewives (56.9%) followed by merchants (13.2%)
and governmental employees (11.0%). One hundred
twenty five (39.3%) of the participants did not attend for-
mal education. The majorities (93.1%) of participants
were married.
Prevalence of HIV and HBV infection
Overall, 21 (6.6%) and 12 (3.8%) of the pregnant women
were HIV and HBsAg positive, respectively. Of these, 4
(19.0%) of pregnant women had both HBV/HIV co-
infections. All HBsAg positive participants were among
orthodox Christian followers. Prevalence of HBV and
HIV did not vary significantly by age, residence, occupa-
tion, educational level, marital status, pregnancy trimes-
ter and income (Table 1).
Associated risk factors for hepatitis B virus and HIV
infection
Multivariate logistic regression analysis was conducted
to assess independent risk factors for HBV and/or HIV
infections. History of blood transfusion (AOR = 3.70,
95% CI, 9.02-14.84), body tattooing (AOR = 5.74, 95%
CI, 1.24-26.50), previous history of surgery (AOR = 11.1,
95% CI, 2.64-46.88) and unsafe injection (AOR = 5.65,
95% CI, 1.44-22.19) were statistically significant risk
factors for HBV infections (Table 2). For HIV infec-
tion, previous history of piercing with sharp materials
(AOR = 3.0, 95% CI 1.17-7.80) and history of abortion
(AOR = 6.6, 95% CI 2.50-17.71) were statistically sig-
nificant (Table 3).
Discussion
In the present study, the overall prevalence of HIV infec-
tion among pregnant women was higher (6.6%) than the
national HIV prevalence among pregnant women (5.3%)
[2]. Likewise, HIV prevalence was higher than the study
conducted in Southern Ethiopia (1.8%) [17] and Mali,
(0.4%) [18]. In contrast, it is lower than reports from
Gondar in Ethiopia [14] and in Nigeria (8.4%) [19]. The
majority of HIV positive participants in this study were
among the age group 21–24 years old. Similarly, 13% of
HIV prevalence was reported in the same age group
(21–24 years) in Gondar, Ethiopia [14]. This age group is
the most vulnerable group for HIV infection.
According to the WHO classification, the prevalence
of HBV among pregnant women in this study was inter-
mediate (2-7%) [3]. The prevalence of HBV infection in
the present study conforms with reports from the study
in Nigeria (3.8%) [19] and Jimma, Ethiopia (3.7%) [15].
However, the prevalence of HBV in the current study
was higher than the study conducted in India (0.9%) [20]
and Tripoli, Libya (1.5%) [21]. In contrast, it was lower
than the study documented in Taiwan (15.5%) [22], Keffi
in Nigeria (6.67%) [23] and Gondar in Ethiopia (7.3%)
[14]. These differences might be attributable to cultural
and behavioral differences for the risk factors of HBV
infection.
The frequency of HBV and HIV co-infection (19.0%)
in this study was higher than the study done in Southern
Ethiopia (0.6%) [17] and Nigeria (9.5%) [19]. Further-
more, the prevalence of HIV infection among HBsAg
positive pregnant women was 33.3%. Most of the time
comorbidity of HBV and HIV infection is common
among risk groups. Because, both HBV and HIV share
common mode of transmission.
Zenebe et al. BMC Infectious Diseases 2014, 14:118 Page 3 of 7
http://www.biomedcentral.com/1471-2334/14/118
Regarding socio-demographic status of the study par-
ticipants, the highest proportion of HBV infection was
among pregnant women who were not literate and those
whose average monthly income was less than one thou-
sand Ethiopian Birr. Likewise, similar finding was also
reported from Jimma in Ethiopia [15]. The highest




Positive N (%) Negative N (%) Positive N (%) Negative N (%)
Residence
Urban 7 (3.3) 207 (96.7) 14 (6.5) 200 (93.5)
Rural 5 (4.5) 99 (95.2) 7 (6.7) 97 (93.3)
Age groups (yrs.)
<21 4 (4.9) 77 (95.1) 3 (3.7) 78 (96.3)
21-24 3 (3.6) 81 (96.4) 7 (8.3) 77 (91.7)
25-30 4 (3.7) 105 (96.3) 8 (7.3) 101 (92.7)
>30 1 (2.3) 43 (97.7) 3 (6.8) 41 (93.2)
Religion
Orthodox 12 (4.4) 262 (95.6) 19 (6.9) 255 (93.1)
Muslim 0 (0.0) 40 (100.0) 2 (5.0) 38 (95.0)
Protestant 0 (0.0) 4 (100.0) 0 (0.0) 4 (100.0)
Occupation
Merchant 1 (2.4) 41 (97.6) 3 (7.1) 39 (92.9)
Student 2 (11.1) 16 (88.9) 2 (11.1) 16 (88.9)
Housewife 6 (3.3) 175 (96.7) 10 (5.5) 171 (94.5)
Day laborer 2 (12.5) 14 (87.5) 2 (12.5) 14 (87.5)
Employer 0 (0.0) 35 (100.0) 3 (8.6) 32 (91.4)
Others 1 (3.8) 25 (96.2) 1 (3.8) 25 (96.2)
Educational status
Not literate 6 (4.8) 119 (95.2) 5 (4.0) 120 (96.0)
Primary level 4 (5.1) 75 (94.9) 10 (12.7) 69 (87.3)
Secondary level 1 (1.7) 58 (98.3) 2 (3.4) 57 (96.2)
Technique level 0 (0.0) 7 (100.0) 2 (28.6) 5 (71.4)
Diploma 1 (3.3) 29 (96.7) 1 (3.3) 29 (96.7)
Degree and above 0 (0.0) 18 (100.0) 1 (5.6) 17 (94.4)
Marital status
Unmarried 1 (6.7) 14 (93.3) 0 (0.0) 14 (100)
Married 9 (3.0) 287 (97) 19 (6.4) 277 (93.6)
Divorced 1 (16.7) 5 (83.3) 2 (33.3) 4 (72.7)
Widowed 1 (100.0) 0 (0.0) 0 (0.0) 1 (100.0)
Average monthly income (Birr)
<1000 7 (5.9) 112 (94.1) 8 (6.7) 111 (93.3)
1000-1500 3 (4.7) 61 (95.3) 5 (7.8) 59 (92.2)
1501-2300 0 (0.0) 58 (100.0) 4 (6.9) 54 (93.1)
>2300 2 (2.6) 75 (97.4) 4 (5.2) 73 (94.8)
Pregnancy stage
1° trimester 0 (0.0) 60 (100.0) 4 (6.7) 56 (93.3)
2° trimester 8 (5.7) 133 (94.3) 9 (6.4) 132 (93.6)
3° trimester 4 (3.5) 113 (96.5) 8 (6.8) 109 (93.2)
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prevalence of HBsAg was detected in pregnant women
who were on a secondary trimester. This was also in line
with the study conducted in Minna, Nigeria [24].
In this study all of the socio-demographic variables
were not statistically significant. However, pregnant
women who had a previous history of blood transfusion
were about 3.7 times more likely to be positive for
HBsAg (AOR = 3.70, CI, 9.02-14.84). A similar study,
which was conducted in Egypt identified this variable as
significant associated factor [25]. Study participants who
have body tattooing on any part of their body was also
5.7 times more likely to be HBsAg positive (AOR = 5.74
CI, 1.24-26.50). Studies conducted from Bamako, Mali
and Addis Ababa, Ethiopia identified that body tattooing
has a significant association with HBV infection [16,26].
Moreover, surgical application was one of the risk factor
which was statistically significant, (AOR = 11.1 CI, 2.64-
46.88) [25].
Unsafe injection like traditional healers’ practice is one
of the risk factors for HBV transmission. In our study,
pregnant women who had a history of unsafe injection
were 5.6 times more likely to be HBV positive (AOR = 5.6
CI, 1.44-22.19). Previous studies showed that patients who
received more injections and injected with non-sterile
needle were more likely to be infected with hepatitis virus
[27]. This practice is also common in our country where
different cultural application on unsafe injection is prac-
ticed. Among explanatory variables, previous history of
piercing with sharp materials (AOR = 3.0, 95% CI 1.17-
7.80) and history of abortion (AOR = 6.6, 95% CI 2.50-
17.71) were significantly associated with HIV infection.
Detection of other markers of HBV like HBeAg and
DNA was not possible because of lack of laboratory setup.
Moreover, HIV/RNA viral load was not determined for
HIV positive pregnant women. These can be considered
as the major limitation of this study.
Table 2 Association of explanatory variables and hepatitis B virus infection among pregnant women attending
antenatal care at Bahir city, 2013 (n = 318)
Variables HBsAg COR (CI) AOR (CI) P- value
Positive N (%) Negative N (%)
History of blood transfusion 8.8 (2.70-29.19)*** 3.7 (9.02-14.84) 0.01
Yes 6 (16.2) 31 (83.8)
No 6 (2.1) 275 (97.9)
History of tooth extraction 7.2 (2.19-23.49)** 2.2 (0.46-10.08) 0.32
Yes 7 (12.3) 50 (87.7)
No 5 (1.9) 256 (98.1)
Tooth tattooing 8.4 (2.44-28.74)** 2.9 (0.67-12.70) 0.15
Yes 8 (11.9) 59 (88.1)
No 4 (1.6) 247 (98.4)
Body tattooing 5.1 (5.36-19.32)** 5.7 (1.24-26.50) 0.02
Yes 9 (7.4) 113 (92.6)
No 3 (1.5) 193 (98.5)
History of surgery 12.9 (3.84-43.37)*** 11.1 (2.64-46.88) 0.001
Yes 6 (21.4) 22 (78.6)
No 6 (2.1) 284 (97.9)
History of unsafe injection 10.2 (3.07-33.73)*** 5.6 (1.44-22.19) 0.01
Yes 7 (15.9) 37 (84.1)
No 5 (1.8) 269 (98.2)
History of abortion 6.6 (1.96-21.99)** 0.6 (0.08-4.29) 0.58
Yes 5 (14.3) 30 (85.7)
No 7 (2.5) 306 (96.2)
HIV/AIDS status 8.5 (2.33-31.07** 0.4 (0.57-2.19) 0.26
Positive 4 (19.0) 17 (81.0)
Negative 8 (2.7) 289 (97.3)
Key: COR (crude odds ratio), AOR (adjusted odds ratio).
***P-value <0.001, **0.05 < p-value >0.001.
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Conclusions
This study showed that HIV and HBV infections are im-
portant public health issues in our region that need to
be addressed. All pregnant women need to be screened
for both HIV and HBV infection during antenatal care.
Blood transfusion, body tattooing, surgery and unsafe in-
jection were risk factors for HBV infection. Moreover,
previous history of piercing with sharp materials and
history of abortion were major risk factors for HIV in-
fection. Thus, health education about these risk factors
in particular and the mode of transmissions and preven-
tion of HIV and HBV in general should be given.
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